| |
| |
|
| Insider
Information: |
Gowen Maxine |
| Relationship: |
Director |
| City: |
W. Conshohocken |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
127,977 |
|
|
Indirect Shares
|
1,581,525 |
|
|
| Direct
Value |
$70,671 |
|
|
|
Indirect Value
|
$169,317 |
|
|
| Total
Shares |
1,709,502 |
|
|
| Total
Value |
$239,988 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -15.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Santarus Inc |
SNTS |
former Director |
2004-04-06 |
20,000 |
2004-10-25 |
1,165,513 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
2008-04-11 |
0 |
Premium* |
|
|
Trevena Inc |
TRVN |
President & CEO, Direc... |
2019-02-01 |
54,000 |
2019-02-01 |
416,012 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2020-06-08 |
24,133 |
2014-11-13 |
0 |
Premium* |
|
|
Aceragen, Inc |
ACGN |
|
2017-01-04 |
17,543 |
2023-08-10 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
Director |
2023-06-02 |
12,301 |
2020-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SNTS |
Santarus Inc |
former Director |
– – – |
2004-03-31 |
5 |
A |
$0.00 |
$0 |
I/I |
1,137,656 |
1,137,656 |
0 |
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2004-04-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,137,656 |
1,137,656 |
|
- |
|
| SNTS |
Santarus Inc |
Director |
– • – |
2004-04-06 |
4 |
B |
$9.00 |
$180,000 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| SNTS |
Santarus Inc |
former Director |
– – – |
2004-10-25 |
5 |
OE |
$1.23 |
$228,500 |
I/I |
27,857 |
1,165,513 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2008-04-11 |
4 |
A |
$6.50 |
$3,192 |
D/D |
491 |
491 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2008-07-11 |
4 |
A |
$5.79 |
$10,000 |
D/D |
1,727 |
2,218 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2008-10-10 |
4 |
A |
$3.71 |
$15,000 |
D/D |
4,043 |
6,261 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2009-01-10 |
4 |
A |
$1.88 |
$13,000 |
D/D |
6,915 |
13,176 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2009-04-10 |
4 |
A |
$0.87 |
$11,500 |
D/D |
13,218 |
26,394 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2009-07-10 |
4 |
A |
$2.53 |
$10,750 |
D/D |
4,249 |
30,643 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2009-10-12 |
4 |
A |
$18.50 |
$10,749 |
D/D |
581 |
31,224 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2010-01-11 |
4 |
A |
$30.82 |
$11,249 |
D/D |
365 |
31,589 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2011-03-21 |
4 |
S |
$27.29 |
$216,293 |
D/D |
(7,926) |
23,663 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
26,163 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2012-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
28,663 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
• • – |
2012-07-30 |
4 |
D |
$14.25 |
$161,312 |
D/D |
(11,320) |
13,177 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
• • – |
2012-07-30 |
4 |
D |
$14.25 |
$247,138 |
D/D |
(17,343) |
0 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEOOfficer |
• • – |
2014-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
193,548 |
|
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2014-04-23 |
4 |
OE |
$0.68 |
$84,893 |
D/D |
124,477 |
318,025 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2014-11-13 |
4 |
B |
$11.82 |
$15,365 |
D/D |
1,300 |
1,300 |
2.39 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2014-12-10 |
4 |
B |
$4.00 |
$32,000 |
D/D |
8,000 |
326,025 |
2.81 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2015-02-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
51,000 |
275,025 |
0 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2016-05-26 |
4 |
B |
$7.19 |
$28,760 |
D/D |
4,000 |
279,025 |
2.81 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2016-05-26 |
4 |
B |
$7.20 |
$28,800 |
I/I |
4,000 |
4,000 |
2.66 |
- |
|
| TRVN |
Trevena Inc |
President & CEO |
• • – |
2016-05-27 |
4 |
B |
$7.08 |
$99,715 |
D/D |
14,084 |
293,109 |
2.81 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
